Influenza A nucleoprotein Antibody (HL1953) - Azide and BSA Free

Lateral Flow Assay: Influenza A nucleoprotein Antibody (HL1953) - Azide and BSA Free [NBP3-25528] - Detection of influenza A virus nucleoprotein by lateral flow assay using the monoclonal antibody pair. Capture: Influenza A virus Nucleoprotein antibody (NBP3-13714 [HL1078]) Detection: Influenza A virus Nucleoprotein antibody (NBP3-25528 [HL1953]) Samples (1 ng) : 1. Influenza A virus Nucleoprotein (A/California/2009 (H1N1)) 2. Influenza A virus Nucleoprotein (A/Hong Kong/2671/2019 (H3N2)) 3. Lysis buffer

Lateral Flow Assay: Influenza A nucleoprotein Antibody (HL1953) - Azide and BSA Free [NBP3-25528] - Detection of nucleoproteins (NP) derived from SARS-CoV-2, Influenza A virus and Influenza B virus by lateral flow assay using the monoclonal antibody pair. Capture: S. SARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL455] A. Influenza A virus Nucleoprotein antibody (NBP3-13714 [HL1078]) B. Influenza B virus Nucleoprotein antibody (NBP3-13713 [HL1073]) Detection: SARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL448] Influenza A virus Nucleoprotein antibody (NBP3-25528 [HL1953]) Influenza B virus Nucleoprotein antibody (NBP3-13708 [HL1068]) Samples (40 ng) : 1. Lysis buffer 2. SARS-CoV-2 (COVID-19) Nucleocapsid protein, His tag 3. Influenza A virus Nucleoprotein (A/California/2009 (H1N1)) 4. Influenza A virus Nucleoprotein (A/Hong Kong/2671/2019 (H3N2)) 5. Influenza B virus Nucleoprotein (B/Sydney/3/2004), DDDDK Tag 6. Influenza B virus Nucleoprotein (B/Victoria/02/1987), DDDDK Tag 7. Mixture of SARS-CoV-2, Flu A-H1N1 and Flu B Nucleoprotein

Lateral Flow Assay: Influenza A nucleoprotein Antibody (HL1953) - Azide and BSA Free [NBP3-25528] - Detection of influenza A virus nucleoprotein by lateral flow assay using the monoclonal antibody pair. Capture: Influenza A virus Nucleoprotein antibody (NBP3-13715 [HL1089]) Detection: Influenza A virus Nucleoprotein antibody (NBP3-25528 [HL1953]) Samples (1 ng) : 1. Influenza A virus Nucleoprotein (A/California/2009 (H1N1)) 2. Influenza A virus Nucleoprotein (A/Hong Kong/2671/2019 (H3N2)) 3. Lysis buffer

• Reactivity: V-Vi
• Applications: LFA
• Clone: HL1953
• Clonality: Monoclonal
• Host: Rabbit
• Conjugate: Unconjugated
• Format: Azide and BSA Free

Influenza A nucleoprotein Antibody (HL1953) - Azide and BSA Free Summary

• Description: Novus Biologicals Rabbit Influenza A nucleoprotein Antibody (HL1953) - Azide and BSA Free (NBP3-25528) is a recombinant monoclonal antibody validated for use in Lateral Flow Assay. All Novus Biologicals antibodies are covered by our 100% guarantee.
• Additional Information: Recombinant Monoclonal Antibody
• Immunogen: Full length Influenza A nucleoprotein ( (A/California/2009/H1N1))
• Source: HEK293
• Isotype: IgG
• Clonality: Monoclonal
• Host: Rabbit
• Purity: Protein A purified

Applications/Dilutions

• Dilutions:
  • Lateral Flow Assay

Packaging, Storage & Formulations

• Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
• Buffer: PBS
• Preservative: No Preservative
• Purity: Protein A purified

Alternate Names for Influenza A nucleoprotein Antibody (HL1953) - Azide and BSA Free

• Influenza A virus NP
• NP
• NP-A
• Nucleocapsid protein
• Nucleoprotein

Background

The nucleoprotein (NP) of Influenza virus encapsulates the negative strand of the viral RNA and is essential for replicative transcription. It may also be involved in other essential functions throughout the virus life cycle. As well as binding ssRNA, NP is able to self associate to form large oligomeric complexes. NP is able to interact with a variety of other macromolecules of both viral and cellular origins. It binds the PB1 and PB2 subunits of the polymerase and the matrix protein M1. "NP has also been shown to interact with at least four cellular polypeptide families: nuclear import receptors of the importin class, filamentous (F) actin, the nuclear export receptor CRM1 and a DEAD box helicase BAT1/UAP56" (Portela et al 2002).

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.